Patient registries: EMA officials highlight opportunities in orphan drug development

Regulatory News

Regulatory NewsFerdous Al-Faruque

Biologics/ biosimilars/ vaccinesBiotechnologyClinical TrialsCombination products/companion diagnosticsDiagnostics/IVDsEuropeMedical DevicesOtherPharmaceuticalsPreclinical studyProduct LifecycleRegulatory Intelligence/PolicyResearch, Design and Development